Perfluorooctyl Bromide Which Empowers the Liquid to Flat the Detached Retina and Displace the Underneath Fluids Anteriorly

Recruiting

• Conditions: Retinal Disease

• Registration Number: NCT05699096
• Lead Sponsor: EL Romany Ophthalmics Factory

Brief Summary

Perfluorohexyloctaneis Essential for Repositioning Giant Retinal Breaks and Can be Used for Removal of Subretinal Fluid as Well as Stabilization of the Retina to Offset

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2023-01-15
• Study First Submitted QC: 2023-01-24
• Study First Posted: 2023-01-26
• Status Verified: 2024-06
• Last Update Submitted: 2024-06-30
• Last Update Posted: 2024-07-03
• Study Start: 2024-09-01
• Primary Completion: 2025-07-01
• Study Completion: 2026-07-01

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

• • Is 20 years or older Has been diagnosed with Keratoconus; Has no other active ocular disease; Is not pregnant or nursing;

Exclusion Criteria

• Is under the age of 20 Has best corrected visual acuity outside 20/400; Pregnant or nursing at the time of enrollment in the study;

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
flat the detached retina and displace the underneath fluids anteriorly	Base line	the effect of Perfluorooctyl Bromide on the retina ,under ophthalmic microscope check the flatted retina

Trial Locations

Locations (1)

Girgis Boules; 🇪🇬 Cairo, Kubri EL Kubba, Egypt